Page last updated: 2024-08-21

3-hydroxyflavone and Cardiac Hypertrophy

3-hydroxyflavone has been researched along with Cardiac Hypertrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bao, XF; Chen, Y; Liu, LL; Luo, HQ; Meng, GL; Sun, LL; Wang, HX; Wang, YQ; Xu, MT; Yu, J; Zhang, JY1
Dai, G; Dong, B; Dong, Y; Fan, W; Huang, H; Jiang, J; Liang, Z; Liu, C; Su, Q; Sun, Y; Wang, Y; Xue, R; Zhao, J1

Other Studies

2 other study(ies) available for 3-hydroxyflavone and Cardiac Hypertrophy

ArticleYear
Dihydromyricetin Attenuates Myocardial Hypertrophy Induced by Transverse Aortic Constriction via Oxidative Stress Inhibition and SIRT3 Pathway Enhancement.
    International journal of molecular sciences, 2018, Aug-31, Volume: 19, Issue:9

    Topics: Animals; Antioxidants; Cardiomegaly; Flavonols; Male; Mice; Mice, Inbred C57BL; Myocardium; Oxidative Stress; Signal Transduction; Sirtuin 3; Ventricular Outflow Obstruction

2018
Fisetin inhibits cardiac hypertrophy by suppressing oxidative stress.
    The Journal of nutritional biochemistry, 2018, Volume: 62

    Topics: Acetylcysteine; Animals; Cardiomegaly; Drug Synergism; Enzymes; Flavonoids; Flavonols; Gene Expression Regulation; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Myocytes, Cardiac; Oxidative Stress; Phenylephrine; TOR Serine-Threonine Kinases

2018
chemdatabank.com